Two Sigma Investments
AEGR

Two Sigma Investments’s Aegerion Pharmaceuticals AEGR Stock Holding History

Two Sigma Investments’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-244,386
Closed -$726K – 3732
2016
Q3 		$726K Sell
244,386
-83,355
-25% -$144K ﹤0.01% 2199
2016
Q2 		$488K Buy
327,741
+255,454
+353% +$584K ﹤0.01% 2268
2016
Q1 		$267K Buy
+72,287
New +$448K ﹤0.01% 2446
2013
Q4 		– Sell
-16,029
Closed -$1.37M – 2504
2013
Q3 		$1.37M Sell
16,029
-4,344
-21% -$368K 0.01% 909
2013
Q2 		$1.29M Buy
+20,373
New +$1.08M 0.01% 1038

Two Sigma Investments's AEGR Position: Q4 2016 in Review

Two Sigma Investments sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 244,386 shares — an estimated $726K sold.

Two Sigma Investments first reported a position in AEGR in Q2 2013 and held it in 5 quarters. The position peaked at $1.37M in Q3 2013. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Two Sigma Investments reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Two Sigma Investments sold 244,386 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $726K.
  • Two Sigma Investments first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Two Sigma Investments's Aegerion Pharmaceuticals position peaked at $1.37M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Two Sigma Investments's 13F filing for Q4 2016, filed 14 Feb 2017.